Browsing by Author Creaney, Jenette

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2012Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural MesotheliomaCheng, Victoria (Yuen); Edelman, John (James); Kao, Steven; Kirschner, Michaela; McCaughan, Brian; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; Badrian, Bahareh; Creaney, Jenette; Klebe, Sonja; Musk, A. W.; Mutsaers, Steven; Robinson, Bruce W.S.; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteIncreased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.7, 7, 2012,pp 1184-1191
2013A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural MesotheliomaBrown, Christopher; Pavlakis, Nick; Stockler, Martin; Bibby, David C; Boyer, Michael; Byrne, Michael J.; Creaney, Jenette; Hughes, Brett; Kremmidiotis, Gabriel; Leske, Annabell; Millward, Michael; Mitchell, Paul L.; Nowak, Anna; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreA phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma, Lung Cancer, vol.81, 3, 2013,pp 422-427